Clinical trial
Fluorouracil and Low-Dose Suramin as Chemosensitization in Treating Patients…
NCT00083109 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00083109 |
|---|---|
| Title | Fluorouracil and Low-Dose Suramin as Chemosensitization in Treating Patients With Metastatic Renal Cell (Kidney) Cancer |
| Official title | Phase I/II Trial Of Low Dose Suramin (CI-1003, NSC#34936) And 5-Fluorouracil In Patients With Metastatic Renal Cell Carcinoma (RCC) |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Recurrent Renal Cell Carcinoma, Stage IV Renal Cell Cancer |
| Intervention type | Drug, Other |
| Interventions | Fluorouracil, Pharmacological Study, Suramin |
| Enrollment | 36 |
| Start date | Mar 1, 2004 |
| Primary completion | Dec 1, 2005 |
| Completion | Mar 1, 2008 |
| First posted | May 17, 2004 |
| Last update posted | May 25, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: